KBS - Pharmaceutical Consultancy and Life Sciences - Market Insight

PRIVATE EQUITY DEALS

JUPITER LIFE SCIENCES CONSULTING ACQUIRED BY THE RIVERSIDE COMPANY

Jupiter, a leading provider of commercial and market access strategies for global pharma, biotech and medical device companies, with its primary focus in rare disease, hematology/ oncology, metabolic and neurology therapeutic areas, was acquired by Riverside, a global private investor focused on the smaller end of the middle market. THCC is a clinically-oriented healthcare consulting firm providing services in strategy, compliance, management and clinical operations for health plans in areas including utili-zation management, care management and value-based care. It received investment from Centre Partners, a middle market private equity firm, and HEP, a healthcare-focused investment firm whose investors include some of the largest health systems and health insurance plans in the US. TONEY HEALTHCARE CONSULTING (THCC) RECEIVED INVESTMENT FROM CENTRE PARTNERS AND HEALTH ENTERPRISE PARTNERS (HEP) Blue Matter, a provider of consultancy services to the global pharmaceutical sector, principally in the areas of product and portfolio strategy, organisational design and product launch planning and readiness, received investment from Baird Capital, which makes venture capital, growth equity and private equity investments in strategically targeted sectors around the world. BLUE MATTER RECEIVED INVESTMENT FROM BAIRD CAPITAL Avalere, headquartered in the UK and with 14 offices on three continents, helps to commercialise more than 300 drug compounds. It received investment from Bridgepoint, one of the world’s leading quoted private asset growth investors with over €67bn of assets under management. AVALERE HEALTH RECEIVED INVESTMENT FROM BRIDGEPOINT Herspiegel, a full-service life science consulting firm that specialises in commercial strategy and execution, received a growth investment from DFW. The investment will accelerate Herspiegel’s growth trajectory, enabling it to expand geographically and in the scope and types of services it offers its clients as it continues to build on its industry-leading capabilities and reach. HERSPIEGEL RECEIVED INVESTMENT FROM DFW CAPITAL PARTNERS AxTalis, a consulting services provider to the pharmaceutical and biotech sectors, received investment from UK lower mid-market private equity firm Kester on behalf of its portfolio company MAP Patient Access. Kester said the AxTalis add-on would “complement MAP’s existing presence in the UK and Ireland” in building a pan-European business. AXTALIS RECEIVED INVESTMENT FROM KESTER CAPITAL